Journals / Turkish Journal of Public Health / 2019 / Cilt: 17 Sayı: 1

Are the students in medicine, nursing and allied health higher schools protected from Hepatitis B: A cross-sectional study from Hatay, Turkey

Tıp, hemşirelik ve sağlık meslek yüksekokulu öğrencileri Hepatit B’den korunuyor mu: Hatay’dan kesitsel bir çalışma, Türkiye

Pages
38–49
Publication Date
2019-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a policy need for all students in healthcare settings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Hepatitis B is an important public health problem and many groups, including health workers, are at risk for hepatitis B.
📊
Key Findings & Data:Method: The study population and sample were 973 students in Mustafa Kemal University, Medical, Nursing and Health Vocational High School in 2015.
💡
Conclusion & Impact:There is a policy need for all students in healthcare settings.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Hepatit B Antikor · sağlık meslekleri öğrencileri · iğne batması

Abstract

Aim: Hepatitis B is an important public health problem and many groups, including health workers, are at risk for hepatitis B. We aimed to determine the hepatitis B surface antibody levels and frequency of needlestick injury among health occupations students. Method: The study population and sample were 973 students in Mustafa Kemal University, Medical, Nursing and Health Vocational High School in 2015. Of the students, %63 were reached, and 67.7% of them gave blood samples. Anti-HBS values were calculated by enzyme-linked immunosorbent assay and an antibody titer over 10 mIU/mL was accepted as positive. Results: The mean age was 20.9 ± 2.7 and 68.5% were female. Anti-HBs positivity was 54.5%, and 37.3% of the vaccinated group was still anti-HBS negative. The difference in anti-hepatitis B positivity was not significant in terms of sex, age group and school, but it was higher in vaccinated students than in others (p <0.05). 29.0% of participants had a history of needle-stick injury. The highest percentage was in health emergency and anaesthesia departments (p <0.001). Needle-stick injury was observed more often in senior students.Conclusion: Approximately half of the students were negative in terms of anti-HBs and injury risk at working places is extremely high. However, there is no clear hepatitis B policy for the students. There is a policy need for all students in healthcare settings.

Özet

Amaç: Hepatit B önemli bir halk sağlığı sorunudur ve sağlık çalışanları dahil pek çok grup hepatit B açısından risk altındadır. Bu çalışmada tıp, hemşirelik ve sağlık meslek yüksekokulu öğrencilerinin anti-hepatit B antikor düzeylerini ve iğne batması sıklığını belirlemek amaçlanmıştır. Yöntem: Çalışmanın evreni ve örneklemi 2015 yılında Mustafa Kemal Üniversitesi Tıp, Hemşirelik ve Sağlık Meslek Yüksek Okulu ilk ve son sınıfında okuyan 973 öğrencidir. Öğrencilerden % 63’üne ulaşılabildi ve bunların % 67.7’sinden kan örneği alındı. Serum örneklerindeki hepatit B yüzey antikoru değerleri “enzyme-linked immunosorbent assay” yöntemiyle çalışıldı, antikor titresi 10 mIU/mL üzeri pozitif kabul edildi. Bulgular: Öğrencilerin yaş ortalaması ve standart sapması 20.9±2.7 olup % 68.5’i kadın idi. Anti-HBs pozitifliği % 54.5 olarak elde edildi. Anti-HBs pozitifliğindeki farklılık cinsiyet, yaş grubu ve okul açısından farksız iken, aşılı olanlarda diğerlerine göre daha yüksek idi (p<0.05). Katılımcıların % 29.0’unda iğne batması öyküsü vardı. En yüksek sıklık sağlık acil ve anestezi bölümü öğrencilerinde idi (p<0.001). Son sınıf öğrencilerinde iğne batması daha sık gözlendi. Sonuç: Öğrencilerin yaklaşık yarısında anti-HBs negatiftir ve çalışma ortamında yaralanma riskleri yüksektir. Buna karşın hepatit B’den korunmak amacı ile staj yapmakta olan öğrenciler için açık bir politika yoktur. Sağlık kuruluşlarında staj yapan öğrencileri işyeri risklerinden koruyacak bir politika gereklidir.

🔖

Cite This Article

İNANDI, T., SAVAŞ, N., Peker, E., DURAN, N., HARMANCI, H. (2019). Are the students in medicine, nursing and allied health higher schools protected from Hepatitis B: A cross-sectional study from Hatay, Turkey. Turkish Journal of Public Health, Cilt: 17 Sayı: 1, 38–49. https://ajindex.com/articles/944322

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. World Health Organization. Global Hepatitis Report.; 2017. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1. Accessed May 4, 2017. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Glob Hepat Program Dep HIV/AIDS. 2016;(June):56. WHO. Hepatitis B vaccines: WHO position paper-Recommendations. Vaccine. 2010;28(3):589-590. doi:10.1016/j.vaccine.2009.10.110. WHO. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec. 2017;27(92):369-392. International Labour Office. List Of Occupational Diseases (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases. http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---safework/documents/publication/wcms_150323.pdf. Accessed May 4, 2017. CDC. Which workers in the health care setting need hepatitis B vaccine? http://www.who.int/occupational_health/activities/3hepatiti.pdf. Accessed March 31, 2017.
  2. Schillie S, Murphy T V, Sawyer M, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013;62(RR-10):1-19. doi:rr6210a1 [pii]. Health Ministery of Tukish Republic. Sağlik Personelinin Bulaşici Hastaliklara Yönelik Tarama Protokolü. https://www.saglik.gov.tr/Eklenti/2867,bdk-kararlaripdf.pdf?0. Accessed March 28, 2017.
  3. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: A historical overview. Vaccine. 2008;26(49):6266-6273. doi:10.1016/j.vaccine.2008.09.056. Nayagam S, Thursz M, Sicuri E, et al. Requirements for global elimination of hepatitis B: a modelling study. Funding Med Res Counc. 2016. doi:10.1016/S1473-3099(16)30204-3.
  4. Toy M, Önder FO, Wörmann T, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11(1):337. doi:10.1186/1471-2334-11-337.
  5. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020-1026. doi:10.1016/j.cmi.2015.06.028. Ay P, Torunoglu MA, Com S, et al. Trends of hepatitis B notification rates in Turkey, 1990 to 2012. Gen Dir Heal Res Minist Heal Euro Surveill. 1990;18(47). www.eurosurveillance.org:pii=20636. Accessed April 1, 2017.
  6. De Schryver A, Claesen B, Me